Friday, 28 September 2018

Friday, September 28, 2018

09.00-10.30

Reproduction in Antiphospholipid Syndrome

Sopra Grande 

Chairs:
Pier Luigi Meroni (Milan, Italy)
Anne Angelillo Scherrer (Bern, Switzerland)

09.00

Pathophysiology of APS
Pier Luigi Meroni (Milan, Italy)

09.20

Outcome in obstetric APS
Angela Tincani (Brescia, Italy)

09.40

Management in normal and refractory APS
Roger Levy (Rio de Janeiro, Brasil)

Abstracts

10.00

Pregnancy outcome and factors associated with pregnancy complications in antiphospholipid antibodies carriers: results from a multicenter Italian study over 20 years of experience
Maria Grazia Lazzaroni (Brescia, Italy)

10.10

Higher sFlt-1/PlGF ratios in HELLP syndrome associated with APS
Fabienne Trottmann (Bern, Switzerland)

10.20

The efficacy of treatment in pregnant women with criteria anti-phospholipid antibodies
Cecilia Chighizola (Cusano Milanino, Italy)

9.00-10.30

Parallel workshop for allied health professionals

Sopra 3

Chairs:
Hege Koksvik (Trondheim, Norway)
Astrid Zbinden (Bern, Switzerland)

09.00

The role of Advanced Practice Midwives in the care of women with chronic conditions
Eva Cignacco (Bern, Switzerland)

09.30

Sexuality in patients with rheumatic diseases
Tone Moksnes (Trondheim, Norway)

Abstracts

10.00

Reproductive Health Outcomes In Women with Psoriatic Arthritis
In the Biologic Era

Kieran Murray (Dublin, Ireland)

10.10

Bridging the Information Gap: Patient Groups develop educational resources for people with arthritis for pregnancy and parenting
Laurie Proulx (Ottawa, Canada)

10.20

Educational and informational needs of patients and health professional concerning pregnancy and rheumatic diseases
Hege Svean Koksvik (Trondheim, Norway)

10.30-11.00

Coffee break

11.00-12.50

Pregnancy in systemic lupus erythematosus

Sopra Grande

Chairs:
Maria Gerosa (Milan Italy)
Angela Tincani (Brescia, Italy)

11.00

Disease activity and pregnancy outcome
Megan Clowse (Durham, United States)

11.20

Predictors for Preeclampsia in SLE
Marc Baumann (Bern, Switzerland)

11.40

Management of severe SLE flares during pregnancy
Rebecca Fischer-Betz (Düsseldorf, Germany)

Abstracts

12.00

Effect of race on pregnancy outcomes in systemic lupus erythematosus: an individual participant meta-analysis
Amanda M Eudy (Durham, United States)

12.10

Adverse pregnancy outcomes (APO) after multi-professional follow-up in
women affected by Systemic Lupus Erythematosus (SLE). Report from a single center in Southern Sweden

Muna Saleh (Helsingborg, Sweden)

12.20

Low aspirin use and high prevalence of preeclampsia risk factors among pregnant women in a multi-national SLE inception cohort
Arielle Mendel (Montreal, Canada)

12.30

Men, SLE and sexual function: an iceberg to ponder
Javier Merayo-Chalico (Mexico City, Mexico)

12.40

Common variable immunodeficiency in a pregnant patient with Systemic Lupus Erythematosus
Isabell Haase (Duesseldorf, Germany)

11.00-12.45

Abstract session

Sopra 3

Chairs:
Eva Cignacco (Bern, Switzerland)
Ursula Von Mandach (Zurich, Switzerland)

11.00

Drug therapy and breastfeeding: compatible or forbidden
Andrea Burch (Zürich, Switzerland)

Abstracts

11.25

Women with rheumatoid arthritis breastfeed their offspring less often and
with a shorter duration compared to women from the general population; results from a nationwide prospective cohort study

Hilal Ince-Askan (Rotterdam, The Netherlands)

11.35

The patient-administered Rheumatoid Arthritis Disease activity index (RADAI) and DAS28-CRP are not interchangeable during pregnancy
Hieronymus Smeele (Rotterdam, The Netherlands)

11.45

Impact of pregnancy on joint damage progression in premenopausal women with rheumatoid arthritis
Deshire Alpizar Rodriguez (Geneva, Switzerland)

11.55

The prevalence of antiphospholipid syndrome in women after preeclampsia: a single tertiary care center experience in Switzerland
Alexandra Maria Neagoe (Bern, Switzerland)

12.05

Long-term follow-up of 320 children born to mothers with systemic autoimmune diseases: a multicentre survey from 24 Rheumatology centers in Italy
Maria Grazia Lazzaroni (Brescia, Italy)

12.15

Lymphocyte changes and vaccination response in a child exposed to belimumab during pregnancy
Helle Bitter (Kristiansand, Norway)

12.25

Defining a standardized core data set for pregnancy registers in rheumatic diseases – an approach of the European Network of Pregnancy registers in rheumatology (EuNeP)
Yvette Meißner (Berlin, Germany)

12.35

A Decade of the Duke Autoimmunity in Pregnancy Registry
Megan Clowse (Durham, United States)

12.45-13.45

Lunch break & Poster viewing

13.45-15.15

Pregnancy in rare diseases

Sopra Grande

Chairs:
Britta Maurer (Zurich, Switzerland)
Peter Villiger (Bern, Switzerland)

13.45

Pregnancy in systemic sclerosis
Antonio Brucato (Bergamo, Italy)

14.05

Pregnancy in Takayasu arteritis
Peter Villiger (Bern, Switzerland)

14.25

Pregnancy in Behçet’s disease
Natalie Costedoat-Chalumeau (Paris, France)

Abstracts

14.45

Pregnancy in Systemic Sclerosis (SSc): Results of Systematic Review and Meta-analysis
Marco Matucci-Cerinic (Florence, Italy)

14.55

International Multicentric PRospective Study on PREgnancy in Systemic Sclerosis (IMPRESS 2): study design and preliminary data
Silvia Breda (Bergamo, Italy)

15.05

Progression to defined rheumatic disease and risk of flare in pregnant women with undifferentiated connective tissue disease: results from a monocentric observational cohort
Véronique Ramoni (Pavia, Italy)

15.15

Pregnancy in granulomatosis with polyangiitis: little known, big challenge
Francesca Motta (Pavia, Italy)

15.25-15.45

Coffee break

15.45-17.15

Complications in the fetus and neonate

Sopra Grande

Chairs:
Luigi Raio (Bern, Switzerland)
Marie Wahren-Herlenius (Stockholm, Sweden)

15.45

Pregnancy in rheumatic diseases: obstetric monitoring
Luigi Raio (Bern, Switzerland)

16.05

Congenital heart block: Mechanism and Risk factors
Marie Wahren-Herlenius (Stockholm, Sweden)

16.25

Treatment and prevention of congenital heart block
Nathalie Costedoat-Chalumeau (Paris, France)

Abstracts

16.45

Results from the Italian Registry of Autoimmune Congenital Heart Block (Lu.Ne Registry): pregnancy, foetal outcomes and recurrence of CHB.
Fredi Micaela (Brescia, Italy)

16.55

sFlt-1, PlGF and VEGF in differential diagnosis between preeclampsia and systemic lupus nephritis - a pilot study
Guilherme de Jesus (Rio de Janeiro, Brazil)

17.05

Analysis of occurrence of small for gestational age infants in women with systemic lupus erythematosus
Bruna Rodrigues (Rio de Janeiro, Brazil)

19.00-21.00

Networking event at Kornhauskeller

The timing and the programme indicated maybe subject to change.